| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |